Skip to main content
letter
. 2021 Oct-Dec;33(4):640–643. doi: 10.5935/0103-507X.20210090

Table 2.

High-flow nasal cannula initial and final settings of all treated patients those with and without epistaxis

Variable Total n = 70 Epistaxis n = 7 No epistaxis n = 63 p value
Flow (L/minute)
Initial 30 [24 - 40] 30 [22.5 - 30] 30 [24 - 40] 0.49
Final 25 [20 - 38.8] 20 [19 - 29] 25 [20 - 40] 0.23
Temperature (°C)
Initial 36 [34.2 - 36] 36 [35.5 - 36] 35 [34 - 36] 0.20
Final 36 [34 - 36] 36 [34 - 36] 36 [34 - 36] 0.90
Fraction of inspired oxygen
Initial 0.50 [0.40 - 0.75] 0.40 [0.40 - 0.55] 0.55 [0.40 - 0.75] 0.34
Final 0.40 [0.30 - 0.70] 0.50 [0.35 - 0.60] 0.40 [0.30 - 0.70] 0.98
Duration of HFNC therapy (days) 2.5 [1 - 5] 4 [0.5 - 11.5] 2 [1 - 5] 0.59

HFNC - high-flow nasal cannula. Results expressed as median [interquartile range].